Close
Nordic 9Nordic 9

Venrock Healthcare Capital Partners (investor - Private Equity)

United States venrockcp.com
See something wrong or missing? Let us know
Offices:Palo Alto
Average round investment:80M USD
Average number per year:1.0
Distribution: 2020 (1)
Portfolio companies: Switzerland Pharvaris
Mostly invests in: Switzerland Switzerland (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Venrock Healthcare Capital Partners

Name Criteria
United States Cormorant Asset Management
80%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Foresite Capital
80%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States venBio Partners
80%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Viking Global Investors
80%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Gilde Healthcare
77%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Bain Capital
74%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States General Atlantic
73%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Famille C Invest
70%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Hitachi Ventures
70%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Polaris Partners
70%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top